Interleukin-1 Receptor Antagonist Suppresses Contact Hypersensitivity
- 1 September 1995
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 105 (3) , 334-338
- https://doi.org/10.1111/1523-1747.ep12320329
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Lymphocyte function-associated antigen-1 is required for maximum elicitation of allergic contact dermatitisBritish Journal of Dermatology, 1994
- Cytokine gene expression in murine epidermal cell suspensions: interleukin 1 beta and macrophage inflammatory protein 1 alpha are selectively expressed in Langerhans cells but are differentially regulated in culture.The Journal of Experimental Medicine, 1992
- In-vivo administration of interleukin 1 both enhances and suppresses contact sensitivity in the mouseBritish Journal of Dermatology, 1992
- Negative Regulation of Interleukin-1 in Immune Reactive CellsImmunological Investigations, 1992
- Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitroImmunology Today, 1991
- Keratinocytes as initiators of inflammationThe Lancet, 1991
- Interleukin-1 receptor antagonist reduces mortality from endotoxin shockNature, 1990
- Cultured Epidermal Langerhans Cells Activate Effector T Cells for Contact SensitivityJournal of Investigative Dermatology, 1990
- Membrane and Cytosolic Interleukin-1 Alpha and Beta in Normal Human Epidermal Cells: Variability of Epitope Exposure in ImmunohistochemistryJournal of Investigative Dermatology, 1990
- The costimulatory function of antigen-presenting cellsImmunology Today, 1990